{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BE-FAST&page=57", "query": { "intervention": "BE-FAST", "page": 57 }, "page_size": 10 }, "pagination": { "page": 57, "page_size": 10, "total_count": 1869, "total_pages": 187, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BE-FAST&page=58&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BE-FAST&page=56&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-11T20:39:29.716Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04027478", "title": "Can Fasting Decrease the Side Effects of Chemotherapy?", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chemotherapy Effect", "Chemotherapeutic Toxicity", "Fasting" ], "interventions": [ { "name": "FMD", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Sutter Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2019-09-01", "completion_date": "2021-02-01", "has_results": false, "last_update_posted_date": "2019-07-22", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04027478" }, { "nct_id": "NCT00965055", "title": "Ezetimibe in Patients Hypo-responsive to Statins", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "High Cholesterol", "Coronary Artery Disease" ], "interventions": [ { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 2, "start_date": "2009-09", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00965055" }, { "nct_id": "NCT05937126", "title": "Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lower Respiratory Tract Infections" ], "interventions": [ { "name": "FilmArray Pneumonia Panel", "type": "DIAGNOSTIC_TEST" }, { "name": "Culture and antimicrobial susceptibility testing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1203, "start_date": "2020-09-15", "completion_date": "2022-09-19", "has_results": false, "last_update_posted_date": "2023-07-10", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05937126" }, { "nct_id": "NCT06053294", "title": "Neural and Metabolic Factors in Carbohydrate Reward", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Carbohydrate Metabolism" ], "interventions": [ { "name": "CS- Beverage", "type": "OTHER" }, { "name": "CS+Fast", "type": "OTHER" }, { "name": "CS+Slow", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Virginia Polytechnic Institute and State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 64, "start_date": "2023-05-01", "completion_date": "2029-05-01", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 1, "location_summary": "Roanoke, Virginia", "locations": [ { "city": "Roanoke", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06053294" }, { "nct_id": "NCT03333837", "title": "Improvisational Movement for People With Memory Loss and Their Caregivers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer's Disease (Incl Subtypes)", "Dementia", "Mild Cognitive Impairment" ], "interventions": [ { "name": "Dance Group", "type": "BEHAVIORAL" }, { "name": "Non-Group Dance", "type": "BEHAVIORAL" }, { "name": "Social Group", "type": "BEHAVIORAL" }, { "name": "No Contact", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "60 Years to 85 Years" }, "enrollment_count": 104, "start_date": "2018-02-06", "completion_date": "2021-05-26", "has_results": true, "last_update_posted_date": "2022-07-27", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03333837" }, { "nct_id": "NCT05253495", "title": "Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-hodgkin Lymphoma", "Hodgkin Lymphoma" ], "interventions": [ { "name": "DOC Group B", "type": "DRUG" }, { "name": "Pv-COMRAD 1 and 2 Group B", "type": "DRUG" }, { "name": "Pv-R-CYM 1 and 2 Group B", "type": "DRUG" }, { "name": "DOC Group C", "type": "DRUG" }, { "name": "MAD CPR 1 and 2", "type": "DRUG" }, { "name": "Pv-R CYVE 1 and 2", "type": "DRUG" }, { "name": "Pv-R CYVE-MTX 1 and 2", "type": "DRUG" }, { "name": "MAD CP", "type": "DRUG" }, { "name": "Pv-Cytarabine/etoposide", "type": "DRUG" }, { "name": "AD CP", "type": "DRUG" }, { "name": "Bv-AVD-R 1 and 2: COHORT IIa", "type": "DRUG" }, { "name": "Bv-NVD-R, Cycle 1-2", "type": "DRUG" }, { "name": "Bv-NVD-R, Cycle 1-4 SER", "type": "DRUG" }, { "name": "Bv-AVD-R", "type": "DRUG" }, { "name": "Bv-NVD-R, Cycle 1-4 RER", "type": "DRUG" }, { "name": "Bv-NAVD-R, Cycle 1-2", "type": "DRUG" }, { "name": "Involved Site Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "New York Medical College", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "3 Years to 39 Years" }, "enrollment_count": 80, "start_date": "2022-02-01", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2025-06-13", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Gainsville, Florida • Vallhala, New York", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gainsville", "state": "Florida" }, { "city": "Vallhala", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05253495" }, { "nct_id": "NCT03927651", "title": "ICG to Assess Ovarian Perfusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Fibroid Uterus", "Endometriosis", "Uterus Myoma", "Uterine Fibroid", "Uterine Adenomyosis", "Endometrial Cyst", "Uterine Cyst" ], "interventions": [ { "name": "ICG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 54, "start_date": "2019-06-01", "completion_date": "2022-11-15", "has_results": false, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03927651" }, { "nct_id": "NCT04718181", "title": "Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Muscular Atrophy, Spinal" ], "interventions": [ { "name": "risdiplam", "type": "DRUG" }, { "name": "omeprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 131, "start_date": "2021-02-01", "completion_date": "2023-01-28", "has_results": false, "last_update_posted_date": "2023-03-13", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 4, "location_summary": "Daytona Beach, Florida • Springfield, Missouri • Dallas, Texas + 1 more", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Dallas", "state": "Texas" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04718181" }, { "nct_id": "NCT04722666", "title": "Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder With Suicidal Ideation With Intent" ], "interventions": [ { "name": "MIJ821 Intravenous Injection", "type": "DRUG" }, { "name": "Placebo Intravenous Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 199, "start_date": "2021-07-20", "completion_date": "2023-09-26", "has_results": true, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 6, "location_summary": "Birmingham, Alabama • Farmington, Connecticut • Oakland Park, Florida + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Oakland Park", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04722666" }, { "nct_id": "NCT07446777", "title": "FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Myeloma", "Monoclonal Gammopathy of Undetermined Significance", "Smoldering Multiple Myeloma" ], "interventions": [ { "name": "Health Coaching", "type": "BEHAVIORAL" }, { "name": "Prolonged Overnight Fasting (POF)", "type": "BEHAVIORAL" }, { "name": "Mediterranean Diet", "type": "BEHAVIORAL" }, { "name": "Supportive Materials", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2026-04-07", "completion_date": "2029-04-30", "has_results": false, "last_update_posted_date": "2026-05-01", "last_synced_at": "2026-11-11T20:39:29.716Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07446777" } ] }